@article{CCO1351,
author = {Katja Sockel and Uwe Platzbecker},
title = {Is it already time for combination treatment in lower risk MDS?},
journal = {Chinese Clinical Oncology},
volume = {1},
number = {2},
year = {2013},
keywords = {},
abstract = {The term myelodysplastic syndrome (MDS) summarizes a range of different hematological disorders, which display peripheral cytopenias as common clinical characteristic. This “ineffective hematopoiesis” is thought to be a result of an imbalance of apoptotic and proliferative signals in bone marrow cells (1).},
issn = {2304-3873}, url = {https://cco.amegroups.org/article/view/1351}
}